spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Smart Bioprocessing with the new Eppendorf Control System

Eppendorf

Flexible and intuitive operation of a wide range of biological processes with the SciVario® twin bioreactor control system.

Hamburg, February 12, 2020



Working with flexible systems that evolve with the changing needs in a lab is indispensable. With the SciVario twin, Eppendorf, a key life science company, introduces its latest bioreactor control system for small- and bench-scale applications. The intelligent controller and new, innovative bay-drawer system enables the exchange of standardized modules to flexibly adapt the controller to the changing requirements in a laboratory.

Smart bioprocessing – The innovative bioprocess controller is equipped with VisioNize® touch interface for easy connectivity to the VisioNize digital lab enabling remote monitoring of processes and custom notifications to users’ mobile devices.

Further intelligent recognition of connected devices and default-settings reduce the risk of operational errors. “All accessories are automatically identified and allow a switch from one to another vessel variant within less than 5 minutes,” states Dr. Patrick Priem, Principal Research Associate at GenMab, Netherlands.

For added flexibility, fourteen integrated TMFCs allow control of microbial and cell culture applications alike without the need to change any hardware components. Additional bioreactor vessel sizes up to 50 L and new functional modules are future introductions along with free intuitive software updates.

“We developed a future-proof bioprocess controller with innovative hardware & software concepts, empowered for future functionality extensions and an incorporation of the digital age.” says Dr. Karl Rix, Head of Business Unit Bioprocess at Eppendorf.
Smart user-interface and application flexibility enable the SciVario twin to fulfill the needs of new and experienced users in academia and industry. It is a premium modular bioprocess control station that will evolve together with users’ research and development needs.
For more information about the SciVario twin, please visit

Press Contact:
David Solbach
Eppendorf AG Bioprocess Center
Rudolf-Schulten-Str. 5
52428 Juelich, Germany 

Tel: +49 2461 980 168
Fax: +49 2461 980 100


About Eppendorf
Eppendorf is a leading life science company that develops and sells instruments, consumables and services for liquid handling, sample handling and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers and cell systems. Consumables such as pipette tips, test tubes, microplates, and single-use bioreactor vessels complement the range of highest-quality premium products.

Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics and at industrial laboratories performing process analysis, production and quality assurance.

Eppendorf was founded in Hamburg, Germany in 1945 and has more than 3,300 employees worldwide. The company has subsidiaries in 26 countries and is represented in all other markets by distributors.
 
phone +49 2461 980 400
email bioprocess-info@eppendorf.de
web www.eppendorf.com
email Bioprocess Center Europe, Rudolf Schulten Str 5, 52428 Juelich
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Europital forecast 30% CAGR from UK biotech for three years

Europital – the global provider of medical management services for clinical research and drug development – announces it is opening a UK site to further expand its services to the UK biotech industry.
More info >>


White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement